Septerna

SEPNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.750 B

$38.83 -1.77%

Close of 7 Aug 2026

Revenue

$46.0M

#2768 by revenue

Earnings

-$48.9M

Loss-making

Shares outstanding

44,906,374

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#127Ascentage Pharma Group InternationalAAPG$1.77B
#128Ani PharmaceuticalsANIP$1.76B
#129SepternaSEPN$1.75B
#130ZymeworksZYME$1.72B
#131Obsidian TherapeuticsOBX$1.70B

Where these numbers come from

Share counts and financials for Septerna are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.